169 related articles for article (PubMed ID: 17917751)
1. Candidate genes for the progression of malignant gliomas identified by microarray analysis.
Bozinov O; Köhler S; Samans B; Benes L; Miller D; Ritter M; Sure U; Bertalanffy H
Neurosurg Rev; 2008 Jan; 31(1):83-9; discussion 89-90. PubMed ID: 17917751
[TBL] [Abstract][Full Text] [Related]
2. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction.
van den Boom J; Wolter M; Kuick R; Misek DE; Youkilis AS; Wechsler DS; Sommer C; Reifenberger G; Hanash SM
Am J Pathol; 2003 Sep; 163(3):1033-43. PubMed ID: 12937144
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction.
van den Boom J; Wolter M; Blaschke B; Knobbe CB; Reifenberger G
Int J Cancer; 2006 Nov; 119(10):2330-8. PubMed ID: 16865689
[TBL] [Abstract][Full Text] [Related]
4. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
Ligon KL; Alberta JA; Kho AT; Weiss J; Kwaan MR; Nutt CL; Louis DN; Stiles CD; Rowitch DH
J Neuropathol Exp Neurol; 2004 May; 63(5):499-509. PubMed ID: 15198128
[TBL] [Abstract][Full Text] [Related]
5. Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas.
Riemenschneider MJ; Koy TH; Reifenberger G
Acta Neuropathol; 2004 Mar; 107(3):277-82. PubMed ID: 14730454
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
8. Decreasing expression of the interleukin-13 receptor IL-13Ralpha2 in treated recurrent malignant gliomas.
Bozinov O; Kalk JM; Krayenbühl N; Woernle CM; Sure U; Bertalanffy H
Neurol Med Chir (Tokyo); 2010; 50(8):617-21. PubMed ID: 20805641
[TBL] [Abstract][Full Text] [Related]
9. ACTB and SDHA Are Suitable Endogenous Reference Genes for Gene Expression Studies in Human Astrocytomas Using Quantitative RT-PCR.
Röhn G; Koch A; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818802318. PubMed ID: 30259794
[TBL] [Abstract][Full Text] [Related]
10. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis.
Rickman DS; Bobek MP; Misek DE; Kuick R; Blaivas M; Kurnit DM; Taylor J; Hanash SM
Cancer Res; 2001 Sep; 61(18):6885-91. PubMed ID: 11559565
[TBL] [Abstract][Full Text] [Related]
11. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
12. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.
Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C
J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313
[TBL] [Abstract][Full Text] [Related]
13. Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas.
Ohnishi A; Sawa H; Tsuda M; Sawamura Y; Itoh T; Iwasaki Y; Nagashima K
J Neuropathol Exp Neurol; 2003 Oct; 62(10):1052-9. PubMed ID: 14575240
[TBL] [Abstract][Full Text] [Related]
14. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays.
Huang H; Colella S; Kurrer M; Yonekawa Y; Kleihues P; Ohgaki H
Cancer Res; 2000 Dec; 60(24):6868-74. PubMed ID: 11156382
[TBL] [Abstract][Full Text] [Related]
16. NPAS3 demonstrates features of a tumor suppressive role in driving the progression of Astrocytomas.
Moreira F; Kiehl TR; So K; Ajeawung NF; Honculada C; Gould P; Pieper RO; Kamnasaran D
Am J Pathol; 2011 Jul; 179(1):462-76. PubMed ID: 21703424
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein Genes are Highly Expressed in Malignant Astrocytomas and Associated with Patient Survival.
Masiulionytė B; Valiulytė I; Tamašauskas A; Skiriutė D
Sci Rep; 2019 Apr; 9(1):5406. PubMed ID: 30932010
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide oligonucleotide microarray analysis of gene-expression profiles of Taiwanese patients with anaplastic astrocytoma and glioblastoma multiforme.
Chang CL
J Biomol Screen; 2008 Oct; 13(9):912-21. PubMed ID: 18812569
[TBL] [Abstract][Full Text] [Related]
19. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques.
Sallinen SL; Sallinen PK; Haapasalo HK; Helin HJ; Helén PT; Schraml P; Kallioniemi OP; Kononen J
Cancer Res; 2000 Dec; 60(23):6617-22. PubMed ID: 11118044
[TBL] [Abstract][Full Text] [Related]
20. DMBT1 homozygous deletion in diffuse astrocytomas is associated with unfavorable clinical outcome.
Motomura K; Mittelbronn M; Paulus W; Brokinkel B; Keyvani K; Sure U; Wrede K; Nakazato Y; Tanaka Y; Pierscianek D; Kim YH; Mariani L; Vital A; Ohgaki H
J Neuropathol Exp Neurol; 2012 Aug; 71(8):702-7. PubMed ID: 22805772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
